Can we target endogenous anti-inflammatory responses as a therapeutic strategy for inflammatory bowel disease?

Ross John Porter, Caroline Andrews, Daniel Paul Brice, Scott Kenneth Durum, Mairi Hall McLean (Lead / Corresponding author)

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Can we target endogenous anti-inflammatory responses as a therapeutic strategy for inflammatory bowel disease?'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience

Keyphrases

Immunology and Microbiology